- QIAGEN und International Panel Physicians Association fördern gemeinsam Bewusstsein für Tuberkulose-Screenings
- PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval
- RS BioTherapeutics Selected for Presentation at American Thoracic Society’s 2024 Respiratory Innovation Summit
- SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Anavex Life Sciences Securities Class Action Lawsuit
- First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
- 3-Day Technical Writing Course for Professionals in the Life Sciences (Webinar: August 5-7, 2024)
- The Tula Foundation receives $92 million donation to supercharge coastal science
- Pharmaceuticals Licensing Agreements Analysis Report 2024 with a Directory of Deals Signed Since 2019
- ProQR Announces Year End 2023 Operating and Financial Results
- ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates